{"schema_version":"secwatch.filing_event.v1","accession":"0001965040-24-000050","form_type":"8-K","ticker":"FTRE","cik":"0001965040","company_name":"Fortrea Holdings Inc.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.289379+00:00","generated_at":"2026-05-31T10:10:38.316962+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fortrea Q2 revenue down 8.6% to $662.4M, net loss $99.3M, cuts full-year guidance","bullets":["Revenue $662.4M (-8.6% YoY); GAAP net loss $99.3M vs net income $25.0M prior year.","Adjusted EBITDA $55.2M vs $71.9M YoY; adjusted loss per share $(0.03).","Book-to-bill 0.96x for Q2; backlog $7.37B; trailing-12-month book-to-bill 1.16x.","Paid down $504M debt using divestiture proceeds from Endpoint Clinical and Patient Access.","Revised FY2024 guidance: revenue $2.70-2.75B, adjusted EBITDA $220-240M, down from prior."],"urls":{"canonical":"https://secwatch.observer/filing/0001965040-24-000050","json":"https://secwatch.observer/filing/0001965040-24-000050.json","markdown":"https://secwatch.observer/filing/0001965040-24-000050.md","text":"https://secwatch.observer/filing/0001965040-24-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1965040/000196504024000050/0001965040-24-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1965040/000196504024000050/ftre-20240812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:10:38.316962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}